Literature DB >> 12383416

The efficacy of papaverine administration by different routes for the treatment of experimental acute cerebral vasospasm.

Hon-Man Liu1, Yong-Kwang Tu.   

Abstract

OBJECTIVE: To compare the effect of papaverine (PPV) by different routes of administration for the treatment of experimental acute cerebral vasospasm.
METHODS: A rabbit model of acute cerebral vasospasm induced by autologous blood injected into the basilar and prepontine cistern was used. The PPV (2mg/kg) was injected either by an intravenous (IV), intra-arterial (IA), intra-cisternal (IC), or combination of intra-arterial and intra-cisternal (IA+IC) routes. Basilar artery diameters were measured before and after vasospasm was induced and after PPV treatment.
RESULTS: Induction of vasospasm reduced basilar artery diameters by more than 50% in all animals. Compared to artery diameters before vasospasm, diameters after PPV treatment via the IV route were only reduced by 0.5+/-4.7%. Other reductions in the diameter included 29.1+/-10.4%, about 1.8+/-3.1%, and about 26.7+/-8.4% in the IA, IC, and IA+IC groups, respectively. However, IA administration of PPV caused obvious side effects.
CONCLUSION: Intra-arterial application of the PPV was the most effective way to treat vasospasm in this study. The efficacy of IC route in our study did not confirm the results of prior study. The possibility of side effects of PPV via the IA route should be considered before clinical application.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12383416     DOI: 10.1054/jocn.2001.1036

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  5 in total

1.  Synthesis, acoustic stability, and pharmacologic activities of papaverine-loaded echogenic liposomes for ultrasound controlled drug delivery.

Authors:  Patrick H Kee; Todd A Abruzzo; Denise A B Smith; Jonathan A Kopechek; Boyu Wang; Shaoling L Huang; Robert C MacDonald; Christy K Holland; David D McPherson
Journal:  J Liposome Res       Date:  2008       Impact factor: 3.648

2.  Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism.

Authors:  Martin Benej; Xiangqian Hong; Sandip Vibhute; Sabina Scott; Jinghai Wu; Edward Graves; Quynh-Thu Le; Albert C Koong; Amato J Giaccia; Bing Yu; Ching-Shih Chen; Ioanna Papandreou; Nicholas C Denko
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-10       Impact factor: 11.205

3.  Anticancer effects of a non-narcotic opium alkaloid medicine, papaverine, in human glioblastoma cells.

Authors:  Mana Inada; Mika Shindo; Kyousuke Kobayashi; Akira Sato; Yohei Yamamoto; Yasuharu Akasaki; Koichi Ichimura; Sei-Ichi Tanuma
Journal:  PLoS One       Date:  2019-05-17       Impact factor: 3.240

4.  Novel Papaverine Metal Complexes with Potential Anticancer Activities.

Authors:  Ahmed Gaber; Walaa F Alsanie; Deo Nandan Kumar; Moamen S Refat; Essa M Saied
Journal:  Molecules       Date:  2020-11-20       Impact factor: 4.411

Review 5.  Emerging strategies to target cancer metabolism and improve radiation therapy outcomes.

Authors:  Martin Kery; Ioanna Papandreou
Journal:  Br J Radiol       Date:  2020-06-23       Impact factor: 3.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.